Celgene Loses Bid To Stay Claims In Thalomid Suit
A federal court refused Friday to stay Barr Laboratories Inc.'s antitrust cross-claims against Celgene Corp. in order to focus first on the patent issues arising from Celgene's suit to block Barr's...To view the full article, register now.
Already a subscriber? Click here to view full article